Producción Académica UCC

New perspectives in the treatment of allergic rhinitis and asthma in children

Baena Cagnani, Carlos E., Passalacqua, Giovanni, Gómez, Maximiliano, Zernotti, Mario Emilio ORCID: and Canonica, Giorgio Walter ORCID: (2007) New perspectives in the treatment of allergic rhinitis and asthma in children. Current Opinion in Allergy and Clinical Immunology, 7 (2). pp. 201-206. ISSN 1473-6322

[img] PDF - Versión aceptada
Disponible bajo Licencia CC Atribución-NoComercial-SinDerivadas 4.0 Internacional.

Descargar (63kB)


PURPOSE OF REVIEW: Allergic rhinitis and asthma are some of the most prevalent chronic diseases in children. Meticulous evaluations of the therapeutic options and interventions are needed to control this burden. The central pathogenic mechanism is an immediate hypersensitivity reaction, followed by interventions in the allergic cascade. Once inflammation is established, potent anti-inflammatory agents or mediator antagonists could help control the phenomenon and reduce the characteristic symptoms related to severity. RECENT FINDINGS: Monoclonal antibody against IgE has demonstrated its efficacy in reducing the symptoms of asthma and rhinitis. In difficult-to-treat asthma patients it allows a reduction in the dose of inhaled steroids, the number of exacerbations, emergency visits and hospitalizations. Its broad implementation is limited by its high cost because adverse events are not a concern. Specific sublingual immunotherapy gave promising results in clinical trials, while modifying immunoglobulins and cytokine profiles, also inducing T-cell tolerance. Safety issues of subcutaneous immunotherapy have been surpassed by the sublingual route, with equivalent efficacy. The new inhaled steroid ciclesonide is effective in established inflammation, is activated only in the respiratory system, and has negligible systemic effects. SUMMARY: Robust evidence on the efficacy and safety of several novel therapies in rhinitis and asthma is available.

Tipo de documento: Artículo
Palabras clave: Allergic diseases. Ciclesonide. Omalizumab. Specific sublingual immunotherapy.
Temas: R Medicina > R Medicina (General)
Unidad académica: Universidad Católica de Córdoba > Facultad de Ciencias de la Salud
Google Académico: Citaciones en Google Académico Ver citaciones
Ver item Editar ítem

Descargas mensuales a lo largo de los últimos 12 meses

Producción Académica UCC soporta OAI 2.0 con una URL base

Sistema de Bibliotecas
Universidad Católica de Córdoba
Campus Universitario. Avenida Armada Argentina 3555
Córdoba, Argentina

Sistema Nacional de Repositorios Digitales (SNRD) EPrints Logo